Leading the worldwide fight to treat and cure Tay-Sachs, Canavan, GM1 and Sandhoff diseases
NTSAD Annual Virtual Family Conference
Thursday, April 22 to Sunday, April 25, 2021 Four days of support for all families coping with Tay-Sachs, Canavan, GM1 Gangliosisdosis, and Sandhoff diseases.
TSHA-101 gene therapy CTA approved in Canada Read More
1
2
3
4
›‹
NTSAD leads the worldwide fight to treat and cure Tay-Sachs, Canavan, GM1, and Sandhoff diseases by driving research, forging collaboration, and fostering community. Supporting families is the center of everything we do.